ADC Therapeutics S.A. (NYSE:ADCT) Q2 2025 Earnings Call Transcript

ADC Therapeutics S.A. (NYSE:ADCT) Q2 2025 Earnings Call Transcript August 12, 2025

ADC Therapeutics S.A. misses on earnings expectations. Reported EPS is $-0.5 EPS, expectations were $-0.36.

Operator: Good morning, ladies and gentlemen, and welcome to the ADC Therapeutics SA ADCT Q2 2025 Earnings Conference Call. [Operator Instructions] This call is being recorded on Tuesday, August 12, 2025. I will now turn the call over to Nicole Riley, Head of Investor Relations and Corporate...